| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |